Progression of diabetic retinopathy and maculopathy after phacoemulsification surgery

International Ophthalmology Clinics

Volumn 50, Issue 1, 2010, Pages 155-166

  Rashid, Saadia ^a   Young, Lucy H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

CATARACT; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; PHACOEMULSIFICATION; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETINA MACULOPATHY; REVIEW; SYSTEMATIC REVIEW;

CATARACT; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; MACULAR DEGENERATION; PHACOEMULSIFICATION; RISK FACTORS;

EID: 75149118537     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181c555cf     Document Type: Review

References (31)

1. Gupta A, Gupta V. Diabetic maculopathy and cataract surgery. Ophthalmol Clin North Am. 2001;14:625-637.
2. Mittra RA, Borrillo JL, Dev S, et al. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol. 2000; 118:912-917.
3. Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy. Early treatment diabetic retinopathy study report number 25. Arch Ophthalmol. 1999;117:1600-1606.
4. Squirrell D, Bhola R, Bush J, et al. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol. 2002;86: 565-571.
5. Romero-Aroca P, Fernández-Ballart J, Almena-Garcia M, et al. Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study. J Cataract Refract Surg. 2006;32:1438-1444.
6. Wagner T, Knaflic D, Rauber M, et al. Influence of cataract surgery on the diabetic eye: a prospective study. Ger J Ophthalmol. 1996;5:79-83.
7. Krepler K, Biowski R, Schrey S, et al. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2002;240:735-738. (Pubitemid 36097101)
8. Flesner P, Sander B, Henning V, et al. Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications. Acta Ophthalmol Scand. 2002;80:19-24.
9. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optic coherence tomography. Ophthalmology. 2007;114: 881-889.
10. Dowler JGF, Hykin PG, Lightman SL, et al. Visual acuity following extracapsular cataract extraction in patients with diabetes. Br J Ophthalmol. 1992;76:221-224.
11. Dowler JG, Sehmi KS, Hykin PG, et al. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology. 1999;106:663-668.
12. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early treatment diabetic retinopathy study report number 2. Ophthalmology. 1987;94:761-774.
13. Mentes J, Erakgun T, Afrashi F, et al. Incidence of cystoid macular edema after uncomplicated phacoemulsification. Ophthalmologica. 2003;216:408-412.
14. Hayashi K, Igarashi C, Hirata A, et al. Changes in diabetic macular edema after phacoemulsification surgery. Eye. 2009;23:389-396.
15. Jaffe GJ, Burton TC, Kuhn E, et al. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1992;114:448-456.
16. Akinci A, Batman C, Zilelioglu O. Does diabetic retinopathy increase the incidence of intraoperative complications of phacoemulsification surgery? Int Ophthalmol. 2005;26: 229-234.
17. Liu Y, Luo L, He M, et al. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients. Eye. 2004;18:900-904.
18. The Diabetes Control and Complications Trial Research Group. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
19. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853. Erratum in: Lancet 1999;354:602.
20. Stratton IM, Cull CA, Adler AI, et al. Additive effects of glycerin and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006;49:1761-1769.
21. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103:1644-1652.
22. Suto C, Hori S, Kato S, et al. Effect of perioperative glycemic control in progression of diabetic retinopathy and maculopathy. Arch Ophthalmol. 2006;124:38-45.
23. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447-1449.
24. Habib MS, Cannon PS, Steel DHW. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal edema and cataract. BMC Ophthalmol. 2005;5:15.
25. Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes. 1997;46:1473-1480. (Pubitemid 27369086)
26. Lam DS, Chan CK, Mohamed S, et al. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular edema: a 6-month prospective pilot study. Eye. 2005;19:885-890.
27. Antonetti DA, Barber AJ, Hollinger LA, et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction protein occludin and zonula occluden: 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem. 1999;274:23463-23467.
28. Funatsu H, Yamashita H, Noma H, et al. Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy. J Cataract Refract Surg. 2002;28:1355-1363.
29. Nauck M, Karakiulakis G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol. 1998;341:309-315.
30. Cheema RA, Al-Mubarak MM, Amin YM, et al. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. J Cataract Refract Surg. 2009;35:18-25.
31. Funatsu H, Yamashita H, Noma H, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefe's Arch Clin Exp Ophthalmol. 2005;243:3-8.